ScreenerHero

MRNA Moderna, Inc.

NAS · US · Healthcare · Biotechnology · modernatx.com
203.21USD0.00%Mkt Cap: 81.13B $P/E: —

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal in…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD
TWST
Twist Bioscience Corporation
$13.59BUSD

Key Statistics

Company
Market Cap81.13B USD
Enterprise Value72.01B USD
Revenue (TTM)2.23B USD
Gross Profit1.05B USD
Net Income (TTM)-2.82B USD
Revenue/Share5.66 USD
Last Price203.21 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4.7K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-42.69
PEG—
EV/EBITDA-32.80
EV/Revenue32.32
P/S34.05
P/B11.21
EPS (TTM)-7.98
EPS (Forward)-4.45
52W Range
22.2897% of range208.90
52W High208.90 USD
52W Low22.28 USD
Profitability
Gross Margin54.84%
Oper. Margin-557.93%
EBITDA Margin-98.52%
Profit Margin-146.83%
ROE-32.62%
ROA-22.87%
Growth
Revenue Growth2.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.87B USD
CapEx (TTM)202.00M USD
FCF Margin13.43%
FCF Yield0.37%
Net Debt-3.85B USD
Net Debt/EBITDA1.75
Balance Sheet
Debt/Equity0.15
Current Ratio2.29
Quick Ratio2.07
Book Value/Sh16.95 USD
Cash/Share12.87 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.8 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)120.67 USD
Upside (mean)-40.6%
Target Range45.00 USD – 170.00 USD
45.00-40.6% to mean170.00
# Analysts18
Ownership
Shares Out.399.24M
Float372.19M
Insiders7.34%
Institutions80.45%
Short Interest
Short Ratio1.0d
Short % Float10.06%
Short % Out.8.23%
Shares Short32.87M
Short (prev mo.)52.81M
Technical
SMA 50123.63 (+64.4%)
SMA 20068.39 (+197.2%)
Beta1.11
S&P 52W Chg14.58%
Avg Vol (30d)23.38M
Avg Vol (10d)16.63M
Technical Indicators
RSI (14)72.2
MACD23.3929
MACD Signal23.8384
MACD Hist.-0.4454
BB Upper221.17 USD
BB Middle170.11 USD
BB Lower119.05 USD
BB Width60.03%
ATR (14)14.04 USD
Vol Ratio (20d)1.29x